US Patent Issued to Amgen on March 17 for "Diagnostic antibodies against mucin 17 and uses thereof" (California Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,322, issued on March 17, was assigned to Amgen Inc. (Thousand Oaks, Calif.).

"Diagnostic antibodies against mucin 17 and uses thereof" was invented by Kurt Edelmann (Thousand Oaks, Calif.) and Julie Bailis (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibodies that bind to human and monkey mucin 17 (MUC17). Moreover, the invention relates to a detection system comprising such antibodies. The antibodies or the detection system may be used for detecting or quantifying MUC17, for diagnosing a disease associated with MUC17, for patient stratification, monitoring disease progression, and evaluat...